Literature DB >> 33107691

The KRAS/Lin28B axis maintains stemness of pancreatic cancer cells via the let-7i/TET3 pathway.

Yawen Liu1, Dawei Wang1, Meng Zhou1, Hui Chen1, Huizhi Wang1, Jingyu Min1, Jiaxi Chen1, Shuhui Wu1, Xiufan Ni1, Youli Zhang1, Aihua Gong2, Min Xu1.   

Abstract

Increasing evidence demonstrates that Lin28B plays critical roles in numerous biological processes including cell proliferation and stemness maintenance. However, the molecular mechanisms underlying Lin28B nuclear translocation remain poorly understood. Here, we found for the first time that KRAS promoted Lin28B nuclear translocation through PKCβ, which directly bound to and phosphorylated Lin28B at S243. Firstly, we observed that Lin28B was upregulated in pancreatic cancer, contributing to cellular migration and proliferation. Furthermore, nuclear Lin28B upregulated TET3 messenger RNA and protein levels by blocking the production of mature let-7i. Subsequently, increased TET3 expression could also promote the expression of Lin28B, thereby forming a Lin28B/let-7i/TET3 feedback loop. Our results suggest that the KRAS/Lin28B axis drives the let-7i/TET3 pathway to maintain the stemness of pancreatic cancer cells. These findings illuminate the distinct mechanism of Lin28B nuclear translocation and its important roles in KRAS-driven pancreatic cancer, and have important implications for development of novel therapeutic strategies for this cancer.
© 2020 The Authors. Molecular Oncology published by John Wiley & Sons Ltd on behalf of Federation of European Biochemical Societies.

Entities:  

Keywords:  KRAS; Lin28B; TET3; let-7; pancreatic cancer

Year:  2020        PMID: 33107691      PMCID: PMC7782082          DOI: 10.1002/1878-0261.12836

Source DB:  PubMed          Journal:  Mol Oncol        ISSN: 1574-7891            Impact factor:   6.603


  36 in total

1.  Cancer statistics, 2019.

Authors:  Rebecca L Siegel; Kimberly D Miller; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2019-01-08       Impact factor: 508.702

2.  Ribonucleoprotein HNRNPA2B1 interacts with and regulates oncogenic KRAS in pancreatic ductal adenocarcinoma cells.

Authors:  Carles Barceló; Julia Etchin; Marc R Mansour; Takaomi Sanda; Mireia M Ginesta; Victor J Sanchez-Arévalo Lobo; Francisco X Real; Gabriel Capellà; Josep M Estanyol; Montserrat Jaumot; A Thomas Look; Neus Agell
Journal:  Gastroenterology       Date:  2014-07-03       Impact factor: 22.682

3.  Novel signaling axis for ROS generation during K-Ras-induced cellular transformation.

Authors:  M-T Park; M-J Kim; Y Suh; R-K Kim; H Kim; E-J Lim; K-C Yoo; G-H Lee; Y-H Kim; S-G Hwang; J-M Yi; S-J Lee
Journal:  Cell Death Differ       Date:  2014-03-14       Impact factor: 15.828

4.  LncRNA UCA1 promotes migration and invasion in pancreatic cancer cells via the Hippo pathway.

Authors:  Meiting Zhang; Yi Zhao; Youli Zhang; Dawei Wang; Shuming Gu; Wen Feng; Wanxin Peng; Aihua Gong; Min Xu
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2018-03-03       Impact factor: 5.187

Review 5.  Regulating the regulator: post-translational modification of RAS.

Authors:  Ian M Ahearn; Kevin Haigis; Dafna Bar-Sagi; Mark R Philips
Journal:  Nat Rev Mol Cell Biol       Date:  2011-12-22       Impact factor: 94.444

6.  The role of Tet3 DNA dioxygenase in epigenetic reprogramming by oocytes.

Authors:  Tian-Peng Gu; Fan Guo; Hui Yang; Hai-Ping Wu; Gui-Fang Xu; Wei Liu; Zhi-Guo Xie; Linyu Shi; Xinyi He; Seung-gi Jin; Khursheed Iqbal; Yujiang Geno Shi; Zixin Deng; Piroska E Szabó; Gerd P Pfeifer; Jinsong Li; Guo-Liang Xu
Journal:  Nature       Date:  2011-09-04       Impact factor: 49.962

7.  Stat3-coordinated Lin-28-let-7-HMGA2 and miR-200-ZEB1 circuits initiate and maintain oncostatin M-driven epithelial-mesenchymal transition.

Authors:  L Guo; C Chen; M Shi; F Wang; X Chen; D Diao; M Hu; M Yu; L Qian; N Guo
Journal:  Oncogene       Date:  2013-01-14       Impact factor: 9.867

8.  K-Ras Promotes Tumorigenicity through Suppression of Non-canonical Wnt Signaling.

Authors:  Man-Tzu Wang; Matthew Holderfield; Jacqueline Galeas; Reyno Delrosario; Minh D To; Allan Balmain; Frank McCormick
Journal:  Cell       Date:  2015-11-19       Impact factor: 41.582

9.  Protein kinase Cα suppresses Kras-mediated lung tumor formation through activation of a p38 MAPK-TGFβ signaling axis.

Authors:  K S Hill; E Erdogan; A Khoor; M P Walsh; M Leitges; N R Murray; A P Fields
Journal:  Oncogene       Date:  2013-04-22       Impact factor: 9.867

10.  Survival of pancreatic cancer cells lacking KRAS function.

Authors:  Mandar Deepak Muzumdar; Pan-Yu Chen; Kimberly Judith Dorans; Katherine Minjee Chung; Arjun Bhutkar; Erin Hong; Elisa M Noll; Martin R Sprick; Andreas Trumpp; Tyler Jacks
Journal:  Nat Commun       Date:  2017-10-23       Impact factor: 14.919

View more
  2 in total

Review 1.  The Role of Feedback Loops in Targeted Therapy for Pancreatic Cancer.

Authors:  Weigang Gu; HongZhang Shen; Lu Xie; Xiaofeng Zhang; Jianfeng Yang
Journal:  Front Oncol       Date:  2022-05-16       Impact factor: 5.738

2.  Vitamin C Sensitizes Pancreatic Cancer Cells to Erastin-Induced Ferroptosis by Activating the AMPK/Nrf2/HMOX1 Pathway.

Authors:  Yawen Liu; Pu Huang; Zheng Li; Chunhui Xu; Huizhi Wang; Baoqing Jia; Aihua Gong; Min Xu
Journal:  Oxid Med Cell Longev       Date:  2022-07-19       Impact factor: 7.310

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.